المؤلفون: Enevoldsen, Frederik C, Sahana, Jayashree, Wehland, Markus, Grimm, Daniela, Infanger, Manfred, Krüger, Marcus

المصدر: Enevoldsen , F C , Sahana , J , Wehland , M , Grimm , D , Infanger , M & Krüger , M 2020 , ' Endothelin Receptor Antagonists : Status Quo and Future Perspectives for Targeted Therapy ' , Journal of Clinical Medicine , vol. 9 , no. 3 , 824 . https://doi.org/10.3390/jcm9030824Test

مصطلحات موضوعية: A-RECEPTOR, B-RECEPTOR, CONTROLLED-TRIAL, ETA-RECEPTOR, GROWTH-FACTOR EXPRESSION, HUMAN BREAST-CANCER, PULMONARY ARTERIAL-HYPERTENSION, RENAL-CELL CARCINOMA, SYSTEMIC-SCLEROSIS, ZIBOTENTAN ZD4054, ambrisentan, atrasentan, bosentan, cancer, cerebral vasospasm, clazosentan, fibrotic disorders, macitentan, pain management, pulmonary arterial hypertension, renal disease, systemic scleroderma, zibotentan

العلاقة: https://pure.au.dk/portal/en/publications/d867ee9d-ae24-4782-b235-53e4da041ebbTest

الإتاحة: https://doi.org/10.3390/jcm9030824Test
https://pure.au.dk/portal/en/publications/d867ee9d-ae24-4782-b235-53e4da041ebbTest

المؤلفون: Enevoldsen, Frederik C, Sahana, Jayashree, Wehland, Markus, Grimm, Daniela, Infanger, Manfred, Krüger, Marcus

المصدر: Journal of Clinical Medicine, Vol 9, Iss 3, p 824 (2020)
Journal of Clinical Medicine
Enevoldsen, F C, Sahana, J, Wehland, M, Grimm, D, Infanger, M & Krüger, M 2020, ' Endothelin Receptor Antagonists : Status Quo and Future Perspectives for Targeted Therapy ', Journal of Clinical Medicine, vol. 9, no. 3, 824 . https://doi.org/10.3390/jcm9030824Test

مصطلحات موضوعية: PULMONARY ARTERIAL-HYPERTENSION, macitentan, ambrisentan, HUMAN BREAST-CANCER, lcsh:Medicine, Review, ZIBOTENTAN ZD4054, A-RECEPTOR, CONTROLLED-TRIAL, GROWTH-FACTOR EXPRESSION, RENAL-CELL CARCINOMA, renal disease, pulmonary arterial hypertension, fibrotic disorders, B-RECEPTOR, cancer, clazosentan, zibotentan, ETA-RECEPTOR, bosentan, atrasentan, SYSTEMIC-SCLEROSIS, lcsh:R, systemic scleroderma, pain management, cerebral vasospasm

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b0f51dd9fd9b30a16d3a1e6de232ab94Test
https://www.mdpi.com/2077-0383/9/3/824Test

المؤلفون: Smollich, Martin, Götte, Martin, Fischgräbe, Jeanett, Macedo, Luciana F., Brodie, Angela, Chen, Shiuan, Radke, Isabel, Kiesel, Ludwig, Wülfing, Pia

المساهمون: Department of Obstetrics and Gynecology, University Hospital Münster - Universitaetsklinikum Muenster Germany (UKM), Department of Pharmacology and Experimental Therapeutics, Department of Surgical Research, Beckman Research Institute of the City of Hope

المصدر: ISSN: 0167-6806.

مصطلحات موضوعية: ZD4054, EDNRA, ET-1, Breast cancer, Aromatase inhibitors, Endothelin

العلاقة: hal-00509361; https://hal.archives-ouvertes.fr/hal-00509361Test; https://hal.archives-ouvertes.fr/hal-00509361/documentTest; https://hal.archives-ouvertes.fr/hal-00509361/file/PEER_stage2_10.1007%252Fs10549-009-0644-2.pdfTest

الإتاحة: https://doi.org/10.1007/s10549-009-0644-2Test
https://hal.archives-ouvertes.fr/hal-00509361Test
https://hal.archives-ouvertes.fr/hal-00509361/documentTest
https://hal.archives-ouvertes.fr/hal-00509361/file/PEER_stage2_10.1007%252Fs10549-009-0644-2.pdfTest

المؤلفون: Jeanett Fischgräbe, Martin Götte, Isabel Radke, Angela Brodie, M. Smollich, Shiuan Chen, Ludwig Kiesel, Luciana Macedo, Pia Wülfing

المساهمون: Department of Obstetrics and Gynecology, University Hospital Münster - Universitaetsklinikum Muenster [Germany] (UKM), Department of Pharmacology and Experimental Therapeutics, Department of Surgical Research, Beckman Research Institute of the City of Hope

المصدر: Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2009, 123 (2), pp.345-357. ⟨10.1007/s10549-009-0644-2⟩

مصطلحات موضوعية: Cancer Research, Pyrrolidines, Time Factors, Estrogen receptor, Pharmacology, ZD4054, EDNRA, Mice, Breast cancer, 0302 clinical medicine, Cell Movement, Antineoplastic Combined Chemotherapy Protocols, Fulvestrant, 0303 health sciences, Endothelin-1, Estradiol, Estrogen Antagonists, Receptor, Endothelin A, Tumor Burden, 3. Good health, Gene Expression Regulation, Neoplastic, Aromatase inhibitors, Oncology, 030220 oncology & carcinogenesis, Female, Breast disease, medicine.drug, Endothelin A Receptor Antagonists, medicine.drug_class, Mice, Nude, Anastrozole, Breast Neoplasms, Endothelin, 03 medical and health sciences, Cell Line, Tumor, Nitriles, medicine, Animals, Humans, Neoplasm Invasiveness, Cell Proliferation, 030304 developmental biology, Aromatase inhibitor, Dose-Response Relationship, Drug, business.industry, Cancer, Triazoles, medicine.disease, Antiestrogen, Xenograft Model Antitumor Assays, ET-1, Tamoxifen, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b327411f0e38ceed4291ca74f4220daTest
https://doi.org/10.1007/s10549-009-0644-2Test

المؤلفون: De Phung, Nicholas D. James, Nancy A. Dawson, Michael Borre, Bernard A. Zonnenberg, Philippe Beuzeboc, Thomas Morris, Armelle Caty

المساهمون: University of Groningen

المصدر: James, N D, Caty, A, Borre, M, Zonnenberg, B A, Beuzeboc, P, Morris, T, Phung, D & Dawson, N A 2008, ' Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic: A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial ', European Urology . https://doi.org/10.1016/j.eururo.2008.11.002Test
European Urology, 55(5), 1112-1123. ELSEVIER SCIENCE BV

مصطلحات موضوعية: Male, Pyrrolidines, Hormone-resistant prostate cancer, Administration, Oral, PROGRESSION, Kaplan-Meier Estimate, ZD4054, GUIDELINES, Gastroenterology, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, Clinical endpoint, Prospective Studies, Prospective cohort study, Pain Measurement, Castration-resistant prostate cancer, Aged, 80 and over, DOCETAXEL, Zibotentan, Hazard ratio, MEN, Middle Aged, Prognosis, Receptor, Endothelin A, Treatment Outcome, SURVIVAL, HEART-FAILURE, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Maximum Tolerated Dose, Endothelin A Receptor Antagonists, Urology, Bone Neoplasms, Adenocarcinoma, Placebo, Risk Assessment, Drug Administration Schedule, ATRASENTAN, Double-Blind Method, Internal medicine, medicine, Humans, Survival analysis, Aged, Neoplasm Staging, Probability, Dose-Response Relationship, Drug, business.industry, Prostatic Neoplasms, Bone metastasis, Prostate-Specific Antigen, Survival Analysis, Surgery, Clinical trial, chemistry, Drug Resistance, Neoplasm, Endothelin-A receptor, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7450de18758c383ac5524f12532f1e04Test
https://doi.org/10.1016/j.eururo.2008.11.002Test

المؤلفون: Andrew Hughes, D J Wilson, David J. Webb, Clive Morris, Jon Curwen, Adam J. Rose

المصدر: British Journal of Cancer

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Endothelin A Receptor Antagonists, Endothelin B Receptor Antagonists, Drug Evaluation, Preclinical, Antineoplastic Agents, Pharmacology, ZD4054, receptor specificity, Radioligand Assay, chemistry.chemical_compound, Internal medicine, Clinical Studies, medicine, Animals, Humans, cancer, Receptor, endothelin A receptor, Clinical Trials as Topic, Endothelin-1, Zibotentan, business.industry, respiratory system, Endothelin 1, volunteer studies, Blockade, Endocrinology, Oncology, chemistry, Vasoconstriction, cardiovascular system, medicine.symptom, Endothelin receptor, business, circulatory and respiratory physiology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1037f7724b460ed87203d475eeb7226Test
https://doi.org/10.1038/sj.bjc.6602676Test

المؤلفون: Cognetti, F, Bagnato, A, Savarese, A, Scambia, G, Sehouli, J, Wimberger, P, Sorio, R, Harter, P, Mari, E, Mcintosh, S, Nathan, F, Pemberton, K, Baumann, K., COLOMBO, NICOLETTA

المساهمون: Cognetti, F, Bagnato, A, Colombo, N, Savarese, A, Scambia, G, Sehouli, J, Wimberger, P, Sorio, R, Harter, P, Mari, E, Mcintosh, S, Nathan, F, Pemberton, K, Baumann, K

مصطلحات موضوعية: Advanced, Cancer, Carboplatin/paclitaxel, Ovarian, ZD4054, Zibotentan, Adult, Aged, Antineoplastic Combined Chemotherapy Protocol, Carboplatin, Disease-Free Survival, Double-Blind Method, Drug Administration Schedule, Female, Human, Middle Aged, Neoplasms, Glandular and Epithelial, Ovarian Neoplasm, Paclitaxel, Placebo, Pyrrolidine, Young Adult, Obstetrics and Gynecology, Oncology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23234805; info:eu-repo/semantics/altIdentifier/wos/WOS:000321092300006; volume:130; issue:1; firstpage:31; lastpage:37; numberofpages:7; journal:GYNECOLOGIC ONCOLOGY; http://hdl.handle.net/10281/72395Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84879093917

الإتاحة: https://doi.org/10.1016/j.ygyno.2012.12.004Test
http://hdl.handle.net/10281/72395Test

المؤلفون: Antonella Savarese, E Mari, Pauline Wimberger, Francesco Cognetti, Giovanni Scambia, Klaus Baumann, Nicoletta Colombo, Kristine Pemberton, F. E. Nathan, P. Harter, Anna Bagnato, Stuart McIntosh, Roberto Sorio, Jalid Sehouli

المساهمون: Cognetti, F, Bagnato, A, Colombo, N, Savarese, A, Scambia, G, Sehouli, J, Wimberger, P, Sorio, R, Harter, P, Mari, E, Mcintosh, S, Nathan, F, Pemberton, K, Baumann, K

المصدر: Gynecologic oncology. 130(1)

مصطلحات موضوعية: Oncology, Pyrrolidines, medicine.medical_treatment, Medizin, Carcinoma, Ovarian Epithelial, ZD4054, Pyrrolidine, Carboplatin, Placebos, chemistry.chemical_compound, Antineoplastic Combined Chemotherapy Protocols, Neoplasms, Glandular and Epithelial, carboplatin/paclitaxel, Cancer, zibotentan, Ovarian Neoplasms, Zibotentan, Obstetrics and Gynecology, Middle Aged, Paclitaxel, Tolerability, Ovarian, Female, Human, Adult, medicine.medical_specialty, Placebo, Disease-Free Survival, Drug Administration Schedule, Young Adult, Double-Blind Method, Internal medicine, medicine, Humans, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Ovarian Neoplasm, medicine.disease, Surgery, Settore MED/40 - GINECOLOGIA E OSTETRICIA, chemistry, Advanced, Ovarian cancer, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd647d4e8e411e2e422e120a87867b1Test
https://pubmed.ncbi.nlm.nih.gov/23234805Test

المؤلفون: James, Nicholas D., Caty, Armelle, Borre, Michael, Zonnenberg, Bernard A., Beuzeboc, Philippe, Morris, Thomas, Phung, De, Dawson, Nancy A.

المصدر: James , N D , Caty , A , Borre , M , Zonnenberg , B A , Beuzeboc , P , Morris , T , Phung , D & Dawson , N A 2009 , ' Safety and Efficacy of the Specific Endothelin-A Receptor Antagonist ZD4054 in Patients with Hormone-Resistant Prostate Cancer and Bone Metastases Who Were Pain Free or Mildly Symptomatic : A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial ' , European Urology , vol. 55 , no. 5 , pp. 1112-1123 . https://doi.org/10.1016/j.eururo.2008.11.002Test ; ISSN:0302-2838

مصطلحات موضوعية: Bone metastasis, Hormone-resistant prostate cancer, Endothelin-A receptor, ZD4054, Castration-resistant prostate cancer, HEART-FAILURE, PROGRESSION, MEN, ATRASENTAN, GUIDELINES, DOCETAXEL, SURVIVAL

الإتاحة: https://doi.org/10.1016/j.eururo.2008.11.002Test
http://hdl.handle.net/11370/4e7f6185-e0fd-44e8-ac85-9b0cb5d4daadTest
https://research.rug.nl/en/publications/safety-and-efficacy-of-the-specific-endothelina-receptor-antagonistTest-zd4054-in-patients-with-hormoneresistant-prostate-cancer-and-bone-metastases-who-were-pain-free-or-mildly-symptomatic(4e7f6185-e0fd-44e8-ac85-9b0cb5d4daad).html

المؤلفون: Cd Morris, A Rose, J Curwen, Am Hughes, Dj Wilson, Dj Webb

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/38/ee/Br_J_Cancer_2005_Jun_20_92(12)_2148-2152.tar.gz

مصطلحات موضوعية: endothelin A receptor, receptor specificity, cancer, volunteer studies, ZD4054

وصف الملف: application/zip

العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.280.9433Test